Trogenix

Developer of precision cancer treatments using its proprietary gene therapy platform

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2023 language trogenix.com

Registered entities

Social engagement

Social engagement: 3.2K social following, 9 posts in the last 12 months — below the industry typical range.

Recent activity

15 Apr 2026
Product launch
Phase I/II ADePT trial for high grade gliomas
25 Feb 2026
Recognition
Coming soon